knowledge -WSS

knowledge

author：leisure time 2025-09-30 08:52:22 - browse：8812

TALLINN, Estonia -- A Belarusian journalist was sentenced Friday to four years in prison after being convicted of aiding extremist activities as the authoritarian country continues a severe crackdown on the opposition and independent reporting.

The trial of video journalist Pavel Padabed was held behind closed doors. His conviction and sentencing were reported by the Belarusian Association of Journalists.

Padabed worked with Belsat, a Polish-funded satellite channel that broadcasts into Belarus and is considered by the Belarusian government to be “extremist media.”

The journalists' association said material presented at his trial included investigative programs about the disappearance of a videographer and the 2016 car bombing in Ukraine of TV journalist Pavel Sharemet.

Belarus President Alexander Lukashenko, in power since 1994, has taken an increasingly repressive line toward the opposition and independent journalists since mass protests engulfed the country in 2020 following a presidential election that gave him a sixth term in office but was widely regarded as fraudulent.

The journalists' association says 34 journalists are currently behind bars.

More than 35,000 people were arrested during the 2020 protests, and many were severely beaten by police. The Belarusian human rights group Viasna says there are nearly 1,500 political prisoners in the country.

Exiled opposition leader Sviatlana Tsikhanouskaya, who ran against Lukashenko in 2020, met Friday with European Council President Charles Michel and EU foreign policy chief Josep Borrell.

Afterward, the European Council issued a statement calling on Belarus to stop allowing Russia to base troops there for use in the war in Ukraine and end the deployment there of Russian tactical nuclear weapons.

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Gene editing the human germline: What are the risks?

WSS

App could help diagnose ear infections more accurately — and at home

AstraZeneca to buy developer of next

3 questions for the future of Biden's cancer moonshot

Phenylephrine and the overlooked value of the placebo effect

What to expect at HLTH 2023, the health care industry conference

Bristol 'take

focus

knowledge

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

A Q&A with the global head of Boehringer Ingelheim's innovation unit

How to save PrEP access — and even expand it

Colonoscopy prep: Liquid

Medicare proposal to cover medical devices draws a mixed reaction

Chemotherapy drug shortage eases slightly but still widespread

Trump demands the U.S. pay no more for drugs than other countries … again

Chan Zuckerberg Biohub Chicago to focus on inflammation

New air purifier tech could be key to improving indoor air quality

AstraZeneca to buy developer of next

focus

Gene editing the human germline: What are the risks?

FDA panel signals lack of confidence in Amgen cancer drug data

Creating egg and sperm cells from stem cells raises ethical issues

When women are denied an abortion, their children fare worse than peers

SCOTUS questions limit to govt efforts to fight misinformation

FDA panel signals lack of confidence in Amgen cancer drug data

hotspot

knowledge

hotspot

entertainment